(Reuters) -U.S. drugmaker Pfizer (NYSE:) stated on Wednesday it's withdrawing its sickle cell illness remedy Oxbryta from all markets the place it's authorised, citing dangers of a painful complication and...
Imagine having a digital twin that will get in poor health, and will be experimented on to establish the very best remedy, with out you having to go close to a capsule or...
Up to date on April twenty sixth, 2023
This text was initially a visitor contribution from Jaren Nichols, the Chief Working Officer at ZipBooks. Jaren was beforehand a Product Supervisor at Google and holds a...
Picture credit: Aer TherapeuticsAer Therapeutics, a biopharmaceutical spin-out firm and a collaboration between College Faculty Dublin (UCD) and the College of California, San Francisco (UCSF), introduced on Friday that it has secured $36M...
Picture credit: Neuromod UnitsDublin-based Neuromod Units, a medtech firm that specialises in neuromodulation, introduced on Thursday that it has secured €30M in a Sequence B spherical of funding. Out of the entire, €15M of...
